2 High-risk vaccine type* | 4 Vaccine type* | 14 High-risk type* | 37 HPV type* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Correlations | Prespecified true Composite prevalence | Composite prevalence estimate§ | Est. to true ratio | Prespecifiedtrue composite prevalence | Composite prevalence estimate§ | Est. to true ratio | Prespecified true composite prevalence | Composite prevalence estimate§ | Est. to true ratio | Prespecified true composite prevalence | Composite prevalence estimate§ | Est. to true ratio |
0 | 0.064 | 0.151 | 2.36 | 0.121 | 0.279 | 2.30 | 0.293 | 0.647 | 2.23 | 0.663 | 0.947 | 1.43 |
0.05 | 0.064 | 0.151 | 2.36 | 0.121 | 0.275 | 2.27 | 0.282 | 0.616 | 2.19 | 0.617 | 0.904 | 1.47 |
0.1 | 0.064 | 0.151 | 2.36 | 0.119 | 0.269 | 2.26 | 0.271 | 0.584 | 2.15 | 0.576 | 0.861 | 1.49 |
0.2 | 0.063 | 0.147 | 2.33 | 0.115 | 0.255 | 2.22 | 0.247 | 0.526 | 2.13 | 0.501 | 0.776 | 1.55 |
0.3 | 0.062 | 0.144 | 2.32 | 0.110 | 0.242 | 2.20 | 0.223 | 0.473 | 2.12 | 0.436 | 0.695 | 1.59 |
0.4 | 0.061 | 0.141 | 2.31 | 0.104 | 0.228 | 2.19 | 0.200 | 0.423 | 2.12 | 0.376 | 0.615 | 1.63 |